The genetics of IgA nephropathy

Nature Clinical Practice Nephrology

Volumn 3, Issue 6, 2007, Pages 325-338

  Beerman, Isabel ^a   Novak, Jan ^b   Wyatt, Robert J ^d   Julian, Bruce A ^c   Gharavi, Ali G ^e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e NONE   (United States)

Author keywords

Familial; Genetic analysis; Glycosylation; IgA nephropathy

Indexed keywords

ANALYTIC METHOD; CHROMOSOME 17Q; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME 6Q; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENOME; HEREDITY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; INHERITANCE PATTERNS; LINKAGE (GENETICS); PEDIGREE;

EID: 34249740772     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0492     Document Type: Review

References (138)

1. van Es LA et al. (1988) Composition of IgA-containing circulating immune complexes in IgA nephropathy. Am J Kidney Dis 12: 397-401
2. Baldree LA et al. (1993) Immunoglobulin A-fibronectin aggregate levels in children and adults with immunoglobulin A nephropathy. Am J Kidney Dis 22: 1-4
3. Stratta P et al. (1996) Incidence of biopsy-proven primary glomerulonephritis in an Italian province. Am J Kidney Dis 27: 631-639
4. Suzuki K et al. (2003) Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63: 2286-2294
5. Cosyns JP et al. (1998) Lesions in donor kidneys: nature, incidence, and influence on graft function. Transpl Int 11: 22-27
6. Rosenberg HG et al. (1990) Morphological findings in 70 kidneys of living donors for renal transplant. Pathol Res Pract 186: 619-624
7. Waldherr R et al. (1989) Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant 4: 943-946
8. D'Amico G (1987) The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64: 709-727
9. Levy M and Berger J (1988) Worldwide perspective of IgA nephropathy. Am J Kidney Dis 12: 340-347
10. Glassock RJ et al. (1985) IgA nephropathy in Japan. Am J Nephrol 5: 127-137
11. Power DA et al. (1985) IgA nephropathy is not a rare disease in the United Kingdom. Nephron 40: 180-184
12. Taguchi T et al. (1987) A comparative study of IgA nephritis in Japan and Germany: an approach to its geopathology. Pathol Res Pract 182: 358-367
13. Abu-Romeh SH et al. (1989) Renal diseases in Kuwait: experience with 244 renal biopsies. Int Urol Nephrol 21: 25-29
14. Cheong I et al. (1991) IgA nephropathy in Malaysia. Southeast Asian J Trop Med Public Health 22: 120-122
15. Briganti EM et al. (2001) The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant 16: 1364-1367
16. Yamagata K et al. (2002) Prognosis of asymptomatic hematuria and/or proteinuria in men: high prevalence of IgA nephropathy among proteinuric patients found in mass screening. Nephron 91: 34-42
17. Gesualdo L et al. (2004) The Italian experience of the national registry of renal biopsies. Kidney Int 66: 890-894
18. Research Group on Progressive Chronic Renal Disease (1999) Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1,850 biopsied cases. Nephron 82: 205-213
19. Galla JH et al. (1984) Racial difference in the prevalence of IgA-associated nephropathies. Lancet 2: 522
20. Smith SM and Hoy WE (1989) Frequent association of mesangial glomerulonephritis and alcohol abuse: a study of 3 ethnic groups. Mod Pathol 2: 138-143
21. Smith SM and Tung KS (1985) Incidence of IgA-related nephritides in American Indians in New Mexico. Hum Pathol 16: 181-184
22. Hoy WE et al. (1993) Mesangial proliferative glomerulonephritis in southwestern American Indians. Am J Kidney Dis 21: 486-496
23. Hoy WE and Megill DM (1989) End-stage renal disease in southwestern Native Americans, with special focus on the Zuni and Navajo Indians. Transplant Proc 21: 3906-3908
24. Hughson MD et al. (1989) Mesangiopathic glomerulonephritis in Zuni (New Mexico) Indians. Arch Pathol Lab Med 113: 148-157
25. O'Connell PJ et al. (1987) Familial IgA nephropathy: a study of renal disease in an Australian aboriginal family. Aust N Z J Med 17: 27-33
26. Casiro OG et al. (1988) The prevalence of IgA nephropathy in Manitoba Native Indian children. Can J Public Health 79: 308-310
27. Wyatt RJ et al. (1998) Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994. Central Kentucky Region of the Southeastern United States IgA Nephropathy DATABANK Project. J Am Soc Nephrol 9: 853-858
28. Sehic AM et al. (1997) Increased recognition of IgA nephropathy in African-American children. Pediatr Nephrol 11: 435-437
29. Barratt J and Feehally J (2005) IgA nephropathy. J Am Soc Nephrol 16: 2088-2097
30. Galla JH (1995) IgA nephropathy. Kidney Int 47: 377-387
31. Donadio JV and Grande JP (2002) IgA nephropathy. N Engl J Med 347: 738-748
32. Tomana M et al. (1997) Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52: 509-516
33. Tomana M et al. (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104: 73-81
34. Kerr MA (1990) The structure and function of human IgA. Biochem J 271: 285-296
35. Mattu TS et al. (1998) The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J Biol Chem 273: 2260-2272
36. Iwasaki H et al. (2003) Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha- L-galactosamine: polypeptide N-acetylgalactosaminyltransferase 2. J Biol Chem 278: 5613-5621
37. Field MC et al. (1989) O-linked oligosaccharides from human serum immunoglobulin A1. Biochem Soc Trans 17: 1034-1035
38. Baenziger JU and Maynard Y (1980) Human hepatic lectin: physiochemical properties and specificity. J Biol Chem 255: 4607-4613
39. Tomana M et al. (1985) Carbohydrate-mediated clearance of secretory IgA from the circulation. Mol Immunol 22: 887-892
40. Allen AC et al. (1995) Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100: 470-474
41. Allen AC et al. (2001) Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 60: 969-973
42. Hiki Y et al. (2001) Mass spectrometry proves under-O- glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59: 1077-1085
43. Smith AC et al. (2006) O-glycosylation of serum IgD in IgA nephropathy. J Am Soc Nephrol 17: 1192-1199
44. Roccatello D et al. (1993) Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients: the role of asialoglycoprotein receptors. Lab Invest 69: 714-723
45. Novak J et al. (2005) IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67: 504-513
46. Moura IC et al. (2004) Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 15: 622-634
47. Moura IC et al. (2005) Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol 16: 2667-2676
48. Greer MR et al. (1998) The nucleotide sequence of the IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 13: 1980-1983
49. Allen AC et al. (1997) Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant 12: 701-706
50. Allen AC et al. (1998) Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 13: 930-934
51. Ju T and Cummings RD (2002) A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A 99: 16613-16618
52. Ju T et al. (2002) Cloning and expression of human core 1 beta1,3-galactosyltransferase. J Biol Chem 277: 178-186
53. Ju T and Cummings RD (2005) Protein glycosylation: chaperone mutation in Tn syndrome. Nature 437: 1252
54. Kudo T et al. (2002) Molecular cloning and characterization of a novel UDP-Gal:GalNAc(alpha) peptide beta 1,3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan. J Biol Chem 277: 47724-47731
55. Moldoveanu Z et al. (2007) Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int [doi:10.1038/sj.ki.5002185]
56. Gharavi A et al. (2006) Are glycosylation defects heritable in familial IgA nephropathy (IgAN) [abstract]? J Am Soc Nephrol 17: 253A
57. Koushik R et al. (2005) Persistent, asymptomatic, microscopic hematuria in prospective kidney donors. Transplantation 80: 1425-1429
58. Vadivel N et al. (2007) Accepting prospective kidney donors with asymptomatic urinary abnormalities: are we shooting in the dark? Kidney Int 71: 173-177
59. Karnib HH et al. (2007) Characterization of large Lebanese family segregating IgA nephropathy. Nephrol Dial Transplant 22: 772-777
60. Tolkoff-Rubin NE et al. (1978) IgA nephropathy in HLA-identical siblings. Transplantation 26: 430-433
61. Sabatier JC et al. (1979) Mesangial IgA glomerulonephritis in HLA-identical brothers. Clin Nephrol 11: 35-38
62. Masuda J et al. (1996) Identical twin sisters with IgA nephropathy [Japanese]. Nippon Jinzo Gakkai Shi 38: 52-56
63. Rambausek M et al. (1985) Hypertension in mesangial IgA glomerulonephritis. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21: 693-697
64. Kabasakal C et al. (1997) IgA nephropathy occurring in two siblings of three families. Turk J Pediatr 39: 395-401
65. Johnston PA et al. (1992) Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy: a report from the MRC Glomerulonephritis Registry. Q J Med 84: 619-627
66. Rambausek M et al. (1987) Familial glomerulonephritis. Pediatr Nephrol 1: 416-418
67. Schena FP et al. (1993) IgA nephropathy: pros and cons for a familial disease. Contrib Nephrol 104: 36-45
68. Scolari F et al. (1999) Familial clustering of IgA nephropathy: further evidence in an Italian population. Am J Kidney Dis 33: 857-865
69. Levy M (1989) Familial cases of Berger's disease and anaphylactoid purpura: more frequent than previously thought. Am J Med 87: 246-248
70. Levy M (1989) Familial cases of Berger's disease or of Berger's disease and rheumatoid purpura. Cooperative study of the Societe Francaise de Nephrologie [French]. Nephrologie 10: 175-182
71. Julian BA et al. (1985) Familial IgA nephropathy: evidence of an inherited mechanism of disease. N Engl J Med 312: 202-208
72. Wyatt RJ et al. (1987) Regionalization in hereditary IgA nephropathy. Am J Hum Genet 41: 36-50
73. Izzi C et al. (2006) Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study. Kidney Int 69: 1033-1040
74. Levy M (2001) Familial cases of Berger's disease and anaphylactoid purpura. Kidney Int 60: 1611-1612
75. Schena FP (1995) Immunogenetic aspects of primary IgA nephropathy. Kidney Int 48: 1998-2013
76. Scolari F et al. (1992) Familial occurrence of primary glomerulonephritis: evidence for a role of genetic factors. Nephrol Dial Transplant 7: 587-596
77. Levy M (1993) Multiplex families in IgA nephropathy. Contrib Nephrol 104: 46-53
78. Schena FP et al. (2002) Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol 13: 453-460
79. Izzi C et al. (2006) IgA nephropathy: the presence of familial disease does not confer an increased risk for progression. Am J Kidney Dis 47: 761-769
80. Frasca GM et al. (2004) Thin basement membrane disease in patients with familial IgA nephropathy. J Nephrol 17: 778-785
81. Scolari F (1999) Familial IgA nephropathy. J Nephrol 12: 213-219
82. Frasca GM et al. (2000) Thin glomerular basement membrane disease. J Nephrol 13: 15-19
83. Julian BA et al. (1991) Macroscopic hematuria and proteinuria preceding renal IgA deposition in patients with IgA nephropathy. Am J Kidney Dis 17: 472-479
84. Lasseur C et al. (1997) Henoch-Schönlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrier. Am J Kidney Dis 29: 285-287
85. Miyagawa S et al. (1989) Anaphylactoid purpura and familial IgA nephropathy. Am J Med 86: 340-342
86. Coppo R et al. (1999) Clinical features of Henoch-Schönlein purpura. Italian Group of Renal Immunopathology. Ann Med Interne (Paris) 150: 143-150
87. Fervenza FC (2003) Henoch-Schönlein purpura nephritis. Int J Dermatol 42: 170-177
88. Patel U et al. (1988) Henoch-Schönlein purpura after influenza vaccination. Br Med J (Clin Res Ed) 296: 1800
89. Sola Alberich R et al. (1997) Henoch-Schönlein purpura associated with acetylsalicylic acid. Ann Intern Med 126: 665
90. Nielsen HE (1988) Epidemiology of Schonlein-Henoch purpura. Acta Paediatr Scand 77: 125-131
91. Yang YH et al. (2005) A nationwide survey on epidemiological characteristics of childhood Henoch-Schönlein purpura in Taiwan. Rheumatology (Oxford) 44: 618-622
92. Cakir N et al. (2004) Henoch-Schönlein purpura in two brothers imprisoned in the same jail: presentation two months apart. Clin Exp Rheumatol 22: 235-237
93. Cosio FG et al. (1994) Association of thin glomerular basement membrane with other glomerulopathies. Kidney Int 46: 471-474
94. Berthoux FC et al. (1995) Primary IgA glomerulonephritis with thin glomerular basement membrane: a peculiar pathological marker versus thin membrane nephropathy association. Contrib Nephrol 111: 1-6
95. Yoshida K et al. (1998) A case of IgA nephropathy in three sisters with thin basement membrane disease. Am J Nephrol 18: 422-424
96. Savige J et al. (2003) Thin basement membrane nephropathy. Kidney Int 64: 1169-1178
97. Frasca GM et al. (2002) Two different glomerular diseases in the same patient at an interval of 7 years. Nephrol Dial Transplant 17: 2014-2016
98. Linossier MT et al. (2003) Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin. Am J Kidney Dis 41: 558-564
99. Risch N and Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273: 1516-1517
100. Lander ES and Botstein D (1986) Mapping complex genetic traits in humans: new methods using a complete RFLP linkage map. Cold Spring Harb Symp Quant Biol 51: 49-62
101. Lander ES and Schork NJ (1994) Genetic dissection of complex traits. Science 265: 2037-2048
102. Gharavi AG et al. (2000) IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26: 354-357
103. Bisceglia L et al. (2006) Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. Am J Hum Genet 79: 1130-1134
104. Beerman I et al. (2004) Replication of linkage and refinement of IGAN1 locus [abstract]. Am J Hum Genet 75A: 1897P
105. Pei Y et al. (2005) Localization of a novel disease susceptibility locus to chromosome 2q36 by genome scan of a large extended Canadian family with IgA nephropathy (IgAN) [abstract]. J Am Soc Nephrol 16 (Suppl): 592A
106. Kruglyak L (1999) Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22: 139-144
107. Heutink P and Oostra BA (2002) Gene finding in genetically isolated populations. Hum Mol Genet 11: 2507-2515
108. Peltonen L (2000) Positional cloning of disease genes: advantages of genetic isolates. Hum Hered 50: 66-75
109. Ott J and Hoh J (2000) Statistical approaches to gene mapping. Am J Hum Genet 67: 289-294
110. Reich DE and Lander ES (2001) On the allelic spectrum of human disease. Trends Genet 17: 502-510
111. Risch NJ (2000) Searching for genetic determinants in the new millennium. Nature 405: 847-856
112. Corder EH et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
113. Takei T et al. (2002) Association between single-nucleotide polymorphisms in selectin genes and immunoglobulin A nephropathy. Am J Hum Genet 70: 781-786
114. Akiyama F et al. (2002) Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy. J Hum Genet 47: 532-538
115. Thibaudin L et al. (2004) G protein beta3 subunit C825T polymorphism in primary IgA nephropathy. Kidney Int 66: 322-328
116. Ohtsubo S et al. (2005) Association of a single-nucleotide polymorphism in the immunoglobulin mu-binding protein 2 gene with immunoglobulin A nephropathy. J Hum Genet 50: 30-35
117. Tuglular S et al. (2003) Polymorphisms of the tumour necrosis factor alpha gene at position -308 and TNFd microsatellite in primary IgA nephropathy. Nephrol Dial Transplant 18: 724-731
118. Masutani K et al. (2003) Impact of interferongamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients. Am J Kidney Dis 41: 371-379
119. Carturan S et al. (2004) Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy. J Nephrol 17: 786-793
120. Li YJ et al. (2004) Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3′ untranslated region of the Megsin gene. J Am Soc Nephrol 15: 1739-1743
121. Li GS et al. (2007) Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int 71: 448-453
122. Kim YS et al. (2001) Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression. Pharmacogenetics 11: 299-305
123. Narita I et al. (2002) Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients. Kidney Int 61: 1853-1858
124. Matsunaga A et al. (2002) Association of the uteroglobin gene polymorphism with IgA nephropathy. Am J Kidney Dis 39: 36-41
125. Harden PN et al. (1995) Polymorphisms in angiotensin-converting- enzyme gene and progression of IgA nephropathy. Lancet 345: 1540-1542
126. Pei Y et al. (1997) Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. J Clin Invest 100: 814-820
127. Yoshioka T et al. (1998) Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis. Arch Dis Child 79: 394-399
128. Yoshida H et al. (1995) Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96: 2162-2169
129. Berthoux FC et al. (2006) CC-chemokine receptor five gene polymorphism in primary IgA nephropathy: the 32 bp deletion allele is associated with late progression to end-stage renal failure with dialysis. Kidney Int 69: 565-572
130. Panzer U et al. (2005) The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy. Kidney Int 67: 75-81
131. Frimat L et al. (2000) Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS - a study of 274 men. J Am Soc Nephrol 11: 2062-2067
132. Santos NM et al. (2002) Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy. Pediatr Nephrol 17: 496-502
133. Altshuler D et al. (2005) A haplotype map of the human genome. Nature 437: 1299-1320
134. Grant SF et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-323
135. Hirschhorn JN and Daly MJ (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6: 95-108
136. Klein RJ et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389
137. Obara W et al. (2003) Association of single-nucleotide polymorphisms in the polymeric immunoglobulin receptor gene with immunoglobulin A nephropathy (IgAN) in Japanese patients. J Hum Genet 48: 293-299
138. Pe'er I et al. (2006) Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat Genet 38: 663-667